Kinisis Ventures

EMBIO Diagnostics Ltd is a biotechnology company based in Nicosia, Cyprus, specializing in innovative sensor technology for the monitoring of air, water, and food quality. The company focuses on developing portable, biosensor-based devices that deliver rapid diagnostics, making them suitable for various industries, including healthcare, food safety, and environmental monitoring. EMBIO's flagship products include the B.EL.D™ (Bio Electric Diagnostics), a portable chemical analyzer that provides real-time results within three minutes, and the airbeld™ System, which offers comprehensive indoor air quality monitoring. By integrating advanced diagnostics with IoT technology and AI analytics, EMBIO empowers businesses and individuals to make informed decisions while addressing critical public health and environmental challenges. The company is committed to sustainability and has established a global presence, delivering its solutions across Europe and the Middle East. Under the leadership of CEO Constantinos Loizou, EMBIO Diagnostics continues to foster partnerships and drive innovation in the field of diagnostics and environmental health.